Overview
Need stronger teeth to tackle your dinner? Straumann Holding could make it possible. The company is a global leader in manufacturing dental implants. The company also makes prosthetics, products for dental tissue regeneration, and the tools and instruments to help install its products. It has introduced a synthetic bone-replacement material to help build up jaw bone in preparation for placing implants, and the company regularly invests in additional
...
Read More research and development efforts. Board member Dr. Thomas Straumann holds about 30% of the company's stock.
Read Less
Read More research and development efforts. Board member Dr. Thomas Straumann holds about 30% of the company's stock.
Read Less
Guillaume Daniellot
See more contacts
Management of Companies and Enterprises
,
Holding companies, nec
?
?
Actual
$2.84 billion
Actual
9.98%
57.81%
$3,618
DEC
?
?
Swiss:STMN
Contacts
Get in Touch with 24 Principals*
-
Guillaume DaniellotManaging Director and Authorised Signatory
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue 2024
$2.84 billion
USD
Actual
1 USD = 0.8807 CHF
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | $549 | $572 | $471 |
| Net Investing Cash | -$400 | -$397 | -$494 |
| Net Financing Cash | -$192 | -$482 | -$175 |
| Net Change in Cash | -$43 | -$306 | -$197 |
| Cash at Beginning of Period | $466 | $790 | $1,000 |
| Cash at End of Period | $426 | $466 | $790 |
| Capital Expenditure | -$190 | -$213 | -$222 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $426 | $466 | $790 |
| Accounts Receivable | $506 | $530 | $473 |
| Inventories | $492 | $417 | $365 |
| Other Current Assets | $305 | $166 | $181 |
| Asset Summary | |||
| Total Current Assets | $1,729 | $1,579 | $1,809 |
| Tangible Fixed Assets | $828 | $804 | $753 |
| Intangible Assets | $352 | $378 | $288 |
| Total Assets | $3,619 | $3,322 | $3,373 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $127 | $106 | $95 |
| Short-Term Debt | $227 | $ | $318 |
| Other Current Liabilities | $716 | $705 | $691 |
| Liability Summary | |||
| Total Current Liabilities | $1,071 | $811 | $1,104 |
| Long-Term Debt | $ | $227 | $227 |
| Other Long-Term Liabilities | $251 | $231 | $38 |
| Total Liabilities | $1,789 | $1,684 | $1,725 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $2 | $2 | $2 |
| Retained Earnings | $2,315 | $2,083 | $2,101 |
| Equity Summary | |||
| Total Equity | $2,317 | $2,085 | $2,102 |
| Shares Outstanding | 159,450,847 | 159,443,481 | 159,354,617 |